Abstract
Purpose
We describe the outcomes of intraocular lens (IOL) explantation in a cluster of opaque multifocal Lentis LS-313 following refractive lens exchange (RLE).
Methods
Single-centre, single-surgeon, retrospective case series.
Results
The study enrolled 10 eyes of 10 patients, 6 male and 4 female. All patients had uneventful RLE with multifocal IOL implantation. The mean patient age at the time of RLE was 53 years ± 2.52 (SD). Two eyes had YAG laser capsulotomy prior to explantation. The mean interval between the initial RLE and IOL explantation was 5.4 years ± 1.4 (SD). IOL exchange was performed in all eyes in one procedure. Five eyes had in the bag hydrophobic acrylic IOL (3 multifocal and 2 monofocal), three eyes had 3-piece hydrophobic acrylic IOL in the ciliary sulcus and two had an anterior chamber IOL. Intraoperatively one patient had weak zonules and two patients had zonular dehiscence and required anterior vitrectomy. The mean preoperative CDVA was 0.25 ± 0.15 (SD) logMAR and at the final follow-up, improved to 0.00 ± 0.07 (SD) logMAR (p < 0.01). Light microscopy with von Kossa stain confirmed IOL calcification. No postoperative complications were recorded.
Conclusions
IOL exchange appears to be a feasible and safe surgical option for multifocal IOL opacification. However, patients must be warned of additional intraoperative risks including zonular dialysis, vitreous loss, retinal detachment and need for potential scleral or iris fixated IOL or anterior chamber IOL (ACIOL) with its associated sequel of complications. Moreover, YAG laser capsulotomy should be considered carefully as it increases the chances of intraoperative complications and restricts the surgical options of secondary IOL insertion such as in-the-bag IOL exchange with MFIOL.
Similar content being viewed by others
References
Packer M, Chu YR, Waltz KL et al (2010) Evaluation of the aspheric tecnis multifocal intraocular lens: one-year results from the first cohort of the Food and Drug Administration clinical trial. Am J Ophthalmol 149(4):577–584
Gierek-Ciaciura S, Cwalina L, Bednarski L, MrukwaKominek E (2010) A comparative clinical study of the visual results between three types of multifocal lenses. Graefes Arch Clin Exp Ophthalmol 248(1):133–140
Alfonso JF, Fernandez-Vega L, Senaris A, Montes-Mico R (2007) Quality of vision with the Acri. Twin asymmetric diffractive bifocal intraocular lens system. J Cataract Refract Surg 33(2):197–202
Mamalis N, Brubaker J, Davis D, Espandar L, Werner L (2008) Complications of foldable intraocular lenses requiring explantation or secondary intervention 2007 survey update. J Cataract Refract Surg 34:1584–1591
Marques N, Marques DMV, Osher RH, Freitas LL (2008) Longitudinal study of intraocular lens exchange. Ophthalmology 115:73–79
Kamiya K, Hayashi K, Shimizu K, Negishi K, Sato M, Bissen-Miyajima H (2014) Multifocal intraocular lens explantation: a case series of 50 eyes. Am J Ophthalmol 158:215–220
Gartaganis S, Prahs P, Lazari E, Gartaganis P, Helbig H, Koutsoukos P (2016) Calcification of hydrophilic acrylic intraocular lenses with a hydrophobic surface: laboratory analysis of 6 cases. Am J Ophthalmol 168:68–77
Park JC, Habib NE, Moate RM (2015) Intraocular lens opacification after corneal endothelial keratoplasty: electron microscopy and x-ray element spectroscopy analysis. J Cataract Refract Surg 41:140–145
Schmidinger G, Pemp B, Werner L (2013) Opacification of an intraocular lens: calcification of hydrophilic intraocular lenses after gas tamponade of the anterior chamber]. Ophthalmologe 110:1066–1068
Werner L, Wilbanks G, Nieuwendaal CP et al (2015) Localized opacification of hydrophilic acrylic intraocular lenses after procedures using intracameral injection of air or gas. J Cataract Refract Surg 41:199–207
Dhital A, Spalton DJ, Goyal S et al (2012) Calcification in hydrophilic intraocular lenses associated with injection of intraocular gas. Am J Ophthalmol 153:1154–1160
Bang SP, Moon K, Lee JH, Jun JH, Joo CK (2019) Subsurface calcification of hydrophilic refractive multifocal intraocular lenses with a hydrophobic surface: a case series. Medicine 9(50):e18379
Yamashita K, Hayashi K, Hata S (2020) Toric Lentis Mplus intraocular lens opacification: a case report. Am J Ophthalmol Case Rep 18:100672
Bhalla M, El-Haddad O, Maurino V (2020) Opacified hydrophilic intraocular lens following DMEK. Eye 34:1925–1926
Marcovich AL, Tandogan T, Bareket M et al (2018) Opacification of hydrophilic intraocular lenses associated with vitrectomy and injection of intraocular gas. BMJ Open Ophthalmol 3:e000157
Gurabardhi M, Heike H, Henning A, Werner L, Pham DT (2018) Serial intraocular lens opacification of different designs from the same manufacturer: Clinical and light microscopic results of 71 explant cases. J Cataract Refract Surg 44:1326–1332
Bompastor-Ramos P, Povoa J, Lobo C, Rodriguez AE, Alio JL, Werner L, Murta JN (2016) Late postoperative opacification of hydrophilic-hydrophobic acrylic intraocular lens. J Cataract Refract Surg 42:1324–1331
Costa JF, Bompastor-Ramos P, Marques M, Henriques J, Póvoa J, Lobo C, Alió JL, Werner L, Murta J (2020) Large-scale opacification of a hydrophilic/hydrophobic intraocular lens. Eur J Ophthalmol 30(2):307–314
Lim AKE, Goh PP, Azura R, Miriam I (2011) Opacification of AcriFlex 50CSE hydrophilic acrylic intraocular lenses. J Cataract Refract Surg 37:655–659
Pandey SK, Werner L, Appie DJ, Kaskalohlu M (2002) Hydrophilic acrylic intraocular lens optic and haptics opacification in a diabetic patient: bilateral case report and clinicopathologic correlation. Ophthalmology 109:2042–2051
Lee D-H, Seo Y, Joo C-K (2002) Progressive opacification of hydrophilic acrylic introcular lenses in diabetic patients. J Cataract Refract Surg 28:1271–1275
Other Cited Material
Field Safety Notice from Oculentis GmbH: Recall for LENTIS HydroSmart foldable intraocular lenses in glass vials. Dec 8, 2014, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). Available at: Urgent Field Safety Notification Oculentis GmbH 2014–001 2014–12–04 Voluntary recall LENTIS HydroSmart foldable Intraocular lens
Field Safety Notice from Oculentis GmbH: Recall for Lentis L or LS or LU by Oculentis BV. Sep 21, 2017, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). Available at: Field Safety Notice Urgent - Field Safety Notice Recall Lentis foldable Intraocular lenses
Oculentis Intraocular Lens Investigation. Foundation for Research and Technology Hellas, Institute of Chemical Engineering Sciences (Forth/ICE-HT), University of Patras, Greece. 30/08/2017. Available at: http://www.oculentis.com/Downloads/StudyPatrasUniversitySummary.pdf
Funding
All authors have no financial disclosure.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by MP, ND and FM. All authors equally wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Author MP, ND, FM and VM declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Phylactou, M., Din, N., Matarazzo, F. et al. Multifocal IOL explantation in patients with opaque lentis after refractive lens exchange. Int Ophthalmol 42, 913–919 (2022). https://doi.org/10.1007/s10792-021-02072-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-02072-w